[Lights and shadows for public health: A critical analysis of the tobacco legislation in Spain].

Luces y sombras para la salud pública: análisis crítico de la legislación sobre el tabaco en España.
Análisis crítico Control del tabaco Critical analysis España Legislation Normativa Spain Tobacco control

Journal

Gaceta sanitaria
ISSN: 1578-1283
Titre abrégé: Gac Sanit
Pays: Spain
ID NLM: 8901623

Informations de publication

Date de publication:
Historique:
received: 07 07 2021
accepted: 08 07 2021
pubmed: 23 8 2021
medline: 22 1 2022
entrez: 22 8 2021
Statut: ppublish

Résumé

Tobacco smoking is a chronic disease that is the leading preventable cause of death in developed countries. In Spain, the prevalence of tobacco use has decreased driven by the implementation of tobacco control policies; however, current legislation does not establish a harmonized regulation for all tobacco products. The aim of this article is to review the current legislation and critically analyze its limitations in relation to the principles of good administration now defined in the Law 39/2015. Spanish in force tobacco control policies main limitations can be divided into four areas: the lack of specific regulation for new tobacco products; the differences in their regulation; the lack of information to the general population on their harmful effects and the new developments in the regulation of smoke-free spaces; and the lack of adaptation of the regulation to the most recent scientific evidence. All in all, the quality of tobacco control regulations in Spain, despite the successes achieved with the Law 28/2005, has been compromised by the State's laxity in the legislative, regulatory, and administrative spheres, which has led to a regulatory stagnation that runs counter to the principles of good regulation. This review should encourage scientific organizations and civil society associations to call for an actualization of the tobacco legislation, with determined and coordinated prevention and control policies to promote a tobacco-free Spain.

Identifiants

pubmed: 34419288
pii: S0213-9111(21)00138-2
doi: 10.1016/j.gaceta.2021.07.001
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Review

Langues

spa

Sous-ensembles de citation

IM

Pagination

48-52

Informations de copyright

Copyright © 2021 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Ariadna Feliu (A)

Unidad de Control del Tabaco, Centro Colaborador de la OMS para el Control del Tabaco, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España; Grupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; Facultad de Medicina y Ciencias de la Salud, Campus de Bellvitge, Universitat de Barcelona, L'Hospitalet del Llobregat, Barcelona, España; CIBER de Enfermedades Respiratorias (CIBERES), España; Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America. Electronic address: afeliu@iconcologia.net.

Cristina Martínez (C)

Unidad de Control del Tabaco, Centro Colaborador de la OMS para el Control del Tabaco, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España; Grupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; Facultad de Medicina y Ciencias de la Salud, Campus de Bellvitge, Universitat de Barcelona, L'Hospitalet del Llobregat, Barcelona, España; CIBER de Enfermedades Respiratorias (CIBERES), España; Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America.

Esteve Fernández (E)

Unidad de Control del Tabaco, Centro Colaborador de la OMS para el Control del Tabaco, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España; Grupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; Facultad de Medicina y Ciencias de la Salud, Campus de Bellvitge, Universitat de Barcelona, L'Hospitalet del Llobregat, Barcelona, España; CIBER de Enfermedades Respiratorias (CIBERES), España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH